The UK reaches UNAIDS 90-90-90 targets

Increased testing and combination prevention efforts mean the UK joins a select list of other countries in achieving the 90-90-90 targets 2 years before the 2020 goal. Tony Kirby reports.

Public Health England (PHE) has announced that, in 2017, the nation achieved the UNAIDS targets of 90% of all people with HIV diagnosed, 90% of those diagnosed on antiretroviral treatment, and 90% of those on treatment virally suppressed. In the UK, 92% of people with HIV are diagnosed, 98% of those diagnosed receive antiretroviral treatment, and 97% of those on treatment are virally suppressed, meaning that 87% of all people with HIV in the country are virally supressed (the UNAIDS target for which is 73%). The UK joins a select list of countries to achieve this target before the 2020 deadline; Botswana, Cambodia, Denmark, Eswatini, Namibia, and the Netherlands have also attained 90-90-90.

Julio Montaner, director of the British Columbia Centre for Excellence in HIV/AIDS in Vancouver, Canada, was the architect of the 90-90-90 target, which was an extension of the treatment-as-prevention paradigm he pioneered more than a decade ago. He is not optimistic that the world will reach the UNAIDS goal. “At the present rate, I have serious doubts we will meet the global 90-90-90 target by 2020 and, as such, we will miss an opportunity to truly deliver on the promise of all the scientific advancements in HIV we have collectively achieved over the last three decades”, says Montaner.

At the time of going to press, the G20 world’s wealthiest nations were meeting in Buenos Aires, Argentina. Montaner says that. In light of overall global funding for HIV stalling in recent years, or even falling, “it is critical for the G20 to redouble their financial commitments to HIV/AIDS, but I have limited hope this is actually going to happen.”

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below